The United Kingdom approved Novo Nordisk's weight-loss pill, marking the company's first entry into the European market with an oral obesity treatment. The regulatory decision allows Novo to compete with injectable rivals using a daily tablet formulation.
Tap to vote and see what everyone thinks.